7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $21M | -$45M | 127.9% | -247.6% | -$36M | — | $20M |
| 2024 | $22M | -$41M | 141.9% | -230.5% | -$29M | — | $28M |
| 2023 | $19M | -$38M | 187.4% | -247.7% | -$25M | — | $47M |
| 2022 | $29M | -$24M | 136.2% | -95.2% | -$33M | — | $11M |
| 2021 | $22M | -$19M | 140.2% | -84.3% | -$15M | — | $48M |
| 2020 | $15M | -$12M | 151.5% | -71.6% | -$11M | — | $19M |
| 2019 | $13M | -$13M | 144.2% | -93.7% | -$10M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $5M | -$5M | 179.6% | -137.4% | -$8M | — | $15M |
| Dec '25 | $5M | -$10M | 118.9% | -234.5% | -$3M | — | $20M |
| Sep '25 | $5M | -$12M | 113.7% | -307.4% | -$8M | — | $13M |
| Jun '25 | $6M | -$12M | 120.0% | -244.3% | -$10M | — | $15M |
| Mar '25 | $6M | -$10M | 154.8% | -214.1% | -$15M | — | $23M |
| Dec '24 | $6M | -$11M | 105.9% | -213.1% | -$8M | — | $28M |
| Sep '24 | $6M | -$12M | 111.1% | -250.4% | -$5M | — | $37M |
| Jun '24 | $5M | -$9M | 180.1% | -241.0% | -$5M | — | $38M |
| Mar '24 | $6M | -$10M | 178.0% | -219.8% | -$11M | — | $22M |
| Dec '23 | $5M | -$5M | 296.3% | -170.2% | $66000 | — | $47M |
| Sep '23 | $4M | -$11M | 173.5% | -335.7% | -$9M | — | $49M |
| Jun '23 | $6M | -$11M | 136.4% | -232.5% | -$11M | — | $55M |
| Mar '23 | $5M | -$11M | 152.6% | -265.5% | -$6M | — | $38M |
| Dec '22 | $8M | -$5M | 140.2% | -87.0% | -$8M | — | $11M |
| Sep '22 | $7M | -$6M | 129.7% | -107.8% | -$9M | — | $43M |
| Jun '22 | $7M | -$8M | 121.6% | -125.2% | -$6M | — | $109M |
| Mar '22 | $7M | -$4M | 153.5% | -60.7% | -$10M | — | $240M |
| Dec '21 | $8M | -$5M | 118.9% | -66.0% | -$2M | — | $48M |
| Sep '21 | $6M | -$3M | 163.9% | -43.6% | -$2M | — | $59M |
| Jun '21 | $4M | -$4M | 149.9% | -104.7% | -$5M | — | $37M |
How the market has priced MXCT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, MAXCYTE, INC.'s revenue has grown 6.3% per year. These are computed facts, not advice.
As of FY2025, MAXCYTE, INC. reported — of total debt against $20M of cash.
In FY2025, gross margin was 127.9%, operating margin -247.6%, and net margin -213.0%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.